Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Byetta1件: Exenatide (Byetta)1件: Exenatide (Byetta (TN)) 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 6, 78, 193 💬
2Byetta 5 micrograms1件: Exenatide (Byetta)1件: Exenatide (Byetta (TN)) 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
3Exenatide
(Byetta (TN))		1件: Exenatide (Byetta)1件: Exenatide (Byetta (TN)) 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬6件: 6, 17, 72, 78, 193, 233 💬
4Exenatide 10 micrograms
(Byetta (TN))		1件: Exenatide (Byetta)1件: Exenatide (Byetta (TN)) 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
5Exenatide 5 micrograms
(Byetta (TN))		1件: Exenatide (Byetta)1件: Exenatide (Byetta (TN)) 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
6Exenatide extended release 2mg (Bydureon)
(Byetta (TN))		1件: Exenatide (Byetta)1件: Exenatide (Byetta (TN)) 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
7Exenatide Pen Injector [Bydureon]
(Byetta (TN))		1件: Exenatide (Byetta)1件: Exenatide (Byetta (TN)) 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 17 💬
8Experimental: GLP1-RA (exenatide) administration
(Byetta (TN))		1件: Exenatide (Byetta)1件: Exenatide (Byetta (TN)) 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 72, 78 💬